Objectives: The objective of this study was to develop a radiomics nomogram for predicting the meningioma grade based on enhanced T1 weighted imaging (T1WI) images. Methods: 188 patients with meningioma were analyzed retrospectively. There were 94 high-grade meningioma to form high-grade group and 94 low-grade meningioma were selected randomly to form low-grade group. Clinical data and MRI features were analyzed and compared. The clinical model was built by using the significant variables. The least absolute shrinkage and selection operator regression was used to select the most valuable radiomics feature. The radiomics signature was built and the Rad-score was calculated. The radiomics nomogram was developed by the significant variables of the clinical factors and Rad-score. The calibration curve and the Hosmer–Lemeshow test were used to evaluate the radiomics nomogram. Different models were compared by Delong test and decision curve analysis curve. Results: The sex, size and surrounding invasion were used to build clinical model. The area under the receiver operator characteristic curve (AUC) of clinical model was 0.870 (95% CI: 0.782–0.959). Nine features were used to construct the radiomics signature. The AUC of the radiomics signature was 0.885 (95% CI: 0.802–0.968). The AUC of radiomics nomogram was 0.952 (95% CI: 0.904–1). The AUC of radiomics nomogram was higher than that of clinical model and radiomics signature with a significant difference (p<0.05). The decision curve analysis curve showed that the radiomics nomogram had a larger net benefit than the clinical model and radiomics signature. Conclusion: The radiomics nomogram based on enhanced T1 weighted imaging images for predicting the meningioma grade showed high predictive value and might contribute to the diagnosis and treatment of meningioma. Advances in knowledge: 1. We first constructed a radiomic nomogram to predict the meningioma grade. 2. We compared the results of the clinical model, radiomics signature and radiomics nomogram.
Objectives: The objective of this study was to compare the predictive performance of 2D and 3D radiomics features in meningioma grade based on enhanced T1 WI images.Methods: There were 170 high grade meningioma and 170 low grade meningioma were selected randomly. The 2D and 3D features were extracted from 2D and 3D ROI of each meningioma. The Spearman correlation analysis and least absolute shrinkage and selection operator (LASSO) regression were used to select the valuable features. The 2D and 3D predictive models were constructed by naive Bayes (NB), gradient boosting decision tree (GBDT), and support vector machine (SVM). The ROC curve was drawn and AUC was calculated. The 2D and 3D models were compared by Delong test of AUCs and decision curve analysis (DCA) curve.Results: There were 1143 features extracted from each ROI. Six and seven features were selected. The AUC of 2D and 3D model in NB, GBDT, and SVM was 0.773 and 0.771, 0.722 and 0.717, 0.733 and 0.743. There was no significant difference in two AUCs (p=0.960, 0.913, 0.830) between 2D and 3D model. The 2D features had a better performance than 3D features in NB models and the 3D features had a better performance than 2D features in GBDT models. The 2D features and 3D features had an equal performance in SVM models.Conclusions: The 2D and 3D features had a comparable performance in predicting meningioma grade. Considering the issue of time and labor, 2D features could be selected for radiomics study in meningioma.Key points: There was a comparable performance between 2D and 3D features in meningioma grade prediction. The 2D features was a proper selection in meningioma radiomics study because of its time and labor saving.
10 January 2024 in Journal of Imaging Informatics in Medicine
Accurate prediction of bone metastasis-free survival (BMFS) after complete surgical resection in patients with non-small cell lung cancer (NSCLC) may facilitate appropriate follow-up planning. The aim of this study was to establish and validate a preoperative CT-based deep learning (DL) signature to predict BMFS in NSCLC patients. We performed a retrospective analysis of 1547 NSCLC patients who underwent complete surgical resection, followed by at least 36 months of monitoring at two hospitals. We constructed a DL signature from multiparametric CT images using 3D convolutional neural networks, and we integrated this signature with clinical-imaging factors to establish a deep learning clinical-imaging signature (DLCS). We evaluated performance using Harrell’s concordance index (C-index) and the time-dependent receiver operating characteristic. We also assessed the risk of bone metastasis (BM) in NSCLC patients at different clinical stages using DLCS. The DL signature successfully predicted BM, with C-indexes of 0.799 and 0.818 for the validation cohorts. DLCS outperformed the DL signature with corresponding C-indexes of 0.806 and 0.834. Ranges for area under the curve at 1, 2, and 3 years were 0.820–0.865 for internal and 0.860–0.884 for external validation cohorts. Furthermore, DLCS successfully stratified patients with different clinical stages of NSCLC as high- and low-risk groups for BM (p < 0.05). CT-based DL can predict BMFS in NSCLC patients undergoing complete surgical resection, and may assist in the assessment of BM risk for patients at different clinical stages.
1 April 2024 in Translational Lung Cancer Research
Background: The occurrence of bone metastasis (BM) will seriously shorten the survival time of lung adenocarcinoma patients and aggravate the suffering of patients. Computed tomography (CT)-based clinical radiomics nomogram may help clinicians stratify the risk of BM in lung adenocarcinoma patients, thereby enabling personalized individualized clinical decision making. Methods: A total of 501 patients with lung adenocarcinoma from March 2017 to March 2019 were enrolled in the study. Based on plain chest CT images, 1130 radiomics features were extracted from each lesion. One-way analysis of variance (ANOVA) and least absolute shrinkage selection operator (LASSO) algorithm were used for radiomics features selection. Univariate and multivariate analyses were used to screen for clinical characteristics and identify independent predictors of BM. Three models (radiomics model, clinical model and combined model) were constructed to predict BM in lung adenocarcinoma patients. Receiver operating characteristic (ROC) curve and decision curve analysis (DCA) were used to evaluate the performance of the three models. The DeLong test was used to compare the performance of the models. Results: Finally, the clinical model for predicting BM in lung adenocarcinoma patients was constructed based on 5 independent predictors: cytokeratin 19-fragments (CYFRA21-1), stage, Ki-67, edge, and lobulation. The radiomics model was constructed based on 5 radiomics features. The combined model incorporating clinical independent predictors and radiomics was constructed. In the validation cohort, the area under the curve (AUC) of the clinical model, radiomics model and combined model was 0.824, 0.842 and 0.866, respectively. Delong test showed that in the training cohort, the AUC values of the radiomics model and the combined model were statistically different (P=0.03), and the AUC values of the other models were not statistically different. DCA showed that the nomogram had a highest net clinical benefit. Conclusions: The CT-based clinical radiomics nomogram can be used as a non-invasive and quantitative method to help clinicians stratify the risk of BM in patients with lung adenocarcinoma, thereby enabling personalized clinical decision making.